The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

Patel Sandip I

Reporting owner CIK 0001843601 · Director

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Patel Sandip IPatel Sandip IPatel Sandip I · August 18, 2026 · Stock award · Stock Option (Right to Buy)Patel Sandip I · August 18, 2026 · Stock award · Stock Option (Right to Buy)Patel Sandip I · October 14, 2026 · Exercise / conversion · American Depositary Shares representing Ordinary SharesPatel Sandip I · October 14, 2026 · Exercise / conversion · American Depositary Shares representing Ordinary SharesPatel Sandip I · October 5, 2026 · Stock award · American Depositary Shares representing Ordinary SharesPatel Sandip I · August 18, 2026 · Stock award · American Depositary Shares representing Ordinary SharesPatel Sandip I · October 1, 2026 · Stock award · Stock Option (right to buy)Patel Sandip I · December 16, 2025 · Purchase · Pre-Funded Warrants to purchase ADRsPatel Sandip I · December 16, 2025 · Purchase · Warrants to purchase ADRsPatel Sandip I · December 16, 2025 · Purchase · Pre-Funded Warrants to purchase ADRsPatel Sandip I · December 16, 2025 · Purchase · Warrants to purchase American Depositary Shares ("ADRs")Dec 16, 2025Oct 14, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

11 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Aug 18, 2026Akari Therapeutics PlcStock Option (Right to Buy)Patel Sandip IStock award
Aug 18, 2026Akari Therapeutics PlcStock Option (Right to Buy)Patel Sandip IStock award
Oct 14, 2026Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary SharesPatel Sandip IExercise / conversion
Oct 14, 2026Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary SharesPatel Sandip IExercise / conversion
Oct 5, 2026Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary SharesPatel Sandip IStock award
Aug 18, 2026Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary SharesPatel Sandip IStock award
Oct 1, 2026AtlasClear Holdings, Inc.Stock Option (right to buy)Patel Sandip IStock award
Dec 16, 2025Akari Therapeutics PlcPre-Funded Warrants to purchase ADRsPatel Sandip IPurchase
Dec 16, 2025Akari Therapeutics PlcWarrants to purchase ADRsPatel Sandip IPurchase
Dec 16, 2025Akari Therapeutics PlcPre-Funded Warrants to purchase ADRsPatel Sandip IPurchase
Dec 16, 2025Akari Therapeutics PlcWarrants to purchase American Depositary Shares ("ADRs")Patel Sandip IPurchase

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Akari Therapeutics PlcAKTX · company listingsStock awardStock Option (Right to Buy)Derivative security · Code A15,0000Value: 0Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsStock awardStock Option (Right to Buy)Derivative security · Code A45,0000Value: 0Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsExercise / conversionAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code M6,1860.0004Value: 2.4744Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsExercise / conversionAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code M3,8660.0004Value: 1.5464Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsStock awardAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code A4,3137.899Value: 34,068.387Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsStock awardAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code A12,1007.899Value: 95,577.9Currency not specifiedView ↗
Trade: AtlasClear Holdings, Inc.ATCH · company listings
Patel Sandip ICFO and General Counsel · Director
Stock awardStock Option (right to buy)Derivative security · Code A777,3320Value: 0Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsPurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P154,6640.4041 *Value: 62,499.7224Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsPurchaseWarrants to purchase ADRsDerivative security · Code P154,664Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsPurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P247,4620.4041 *Value: 99,999.3942Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsPurchaseWarrants to purchase American Depositary Shares ("ADRs")Derivative security · Code P247,462Not reported *Value: Not reportedCurrency not specifiedView ↗